Timken’s shares have sunk to $76.64, producing a disappointing 6.7% loss while the S&P 500 was flat. This might have ...
restor3d will continue working closely with leading orthopedic surgeons during the limited market release in Q3 2025, ensuring that the Identity Personalized Knee Cementless System meets the highest ...
The Timken Company ( NYSE:TKR ), might not be a large cap stock, but it received a lot of attention from a substantial... Over the last six months, Timken’s shares have sunk to $76.64 ...
Robotic-assisted TKR leverages precise measurements and real ... the Robotic system creates a detailed 3D model of the patient's knee. This model allows the surgeon to meticulously plan the ...
Total knee replacement is an operation frequently needed by hemophilia patients, which greatly improves their quality of life. This operation, however, carries a higher risk of bleeding and ...